ES269442A1 - Procedimiento de preparaciën de orotato de lisina - Google Patents
Procedimiento de preparaciën de orotato de lisinaInfo
- Publication number
- ES269442A1 ES269442A1 ES0269442A ES269442A ES269442A1 ES 269442 A1 ES269442 A1 ES 269442A1 ES 0269442 A ES0269442 A ES 0269442A ES 269442 A ES269442 A ES 269442A ES 269442 A1 ES269442 A1 ES 269442A1
- Authority
- ES
- Spain
- Prior art keywords
- properties
- lysine orotate
- orotate
- galactogenic
- cyrrhosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- FVGJURXBWORGKL-JEDNCBNOSA-N (2s)-2,6-diaminohexanoic acid;2,4-dioxo-1h-pyrimidine-6-carboxylic acid Chemical compound NCCCC[C@H](N)C(O)=O.OC(=O)C1=CC(=O)NC(=O)N1 FVGJURXBWORGKL-JEDNCBNOSA-N 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 230000001673 galactogenic effect Effects 0.000 abstract 1
- 230000002440 hepatic effect Effects 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 238000001243 protein synthesis Methods 0.000 abstract 1
- 230000008929 regeneration Effects 0.000 abstract 1
- 238000011069 regeneration method Methods 0.000 abstract 1
- 239000000829 suppository Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000014616 translation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR834523A FR88M (es) | 1960-07-29 | 1960-07-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES269442A1 true ES269442A1 (es) | 1962-01-01 |
Family
ID=8736588
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES0269442A Expired ES269442A1 (es) | 1960-07-29 | 1961-07-28 | Procedimiento de preparaciën de orotato de lisina |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US3161565A (es) |
| BE (1) | BE606638A (es) |
| CH (1) | CH394216A (es) |
| DK (1) | DK105811C (es) |
| ES (1) | ES269442A1 (es) |
| FR (1) | FR88M (es) |
| GB (1) | GB922361A (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3011437A1 (de) * | 1980-03-25 | 1981-10-01 | Hrvoje Dr. Zagreb Krnjevic | Pharmazeutisches mittel zur heilung von entzuendlichen und/oder degenerativen und/oder atrophischen schleimhauterkrankungen |
| US7776838B1 (en) | 1987-10-28 | 2010-08-17 | Wellstat Therapeutics Corporation | Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
| US5691320A (en) * | 1987-10-28 | 1997-11-25 | Pro-Neuron, Inc. | Acylated pyrimidine nucleosides for treatment of systemic inflammation and inflammatory hepatitis |
| US5736531A (en) | 1987-10-28 | 1998-04-07 | Pro-Neuron, Inc. | Compositions of chemotherapeutic agent or antiviral agent with acylated pyrimidine nucleosides |
| US5470838A (en) * | 1987-10-28 | 1995-11-28 | Pro-Neuron, Inc. | Method of delivering exogenous uridine or cytidine using acylated uridine or cytidine |
| CN101066276A (zh) * | 1994-07-01 | 2007-11-07 | 威尔斯塔特医疗公司 | 用于治疗全身性炎症和炎性肝炎的嘧啶核苷酸前体 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2556907A (en) * | 1950-01-27 | 1951-06-12 | Du Pont | Resolution of lysine |
| US2738299A (en) * | 1953-05-11 | 1956-03-13 | Abbott Lab | Stable nutritive amino acid compositions |
| US2802864A (en) * | 1953-09-01 | 1957-08-13 | Int Minerals & Chem Corp | Higher alkyl amine salts of glutamic acid |
| US2992163A (en) * | 1955-11-07 | 1961-07-11 | Lilly Co Eli | Use of 4-chloro-1, 2-pyrazole for controlling epileptic seizures |
| US2859244A (en) * | 1956-09-28 | 1958-11-04 | Dow Chemical Co | Resolution of dl-lysine with d-camphoric acid |
| US3020278A (en) * | 1959-09-16 | 1962-02-06 | Jr Edgar A Ferguson | Vitamin-orotic acid compositions |
| US3062722A (en) * | 1960-03-15 | 1962-11-06 | Garofalo Domenico | Therapeutic 2-aminoethanethiol orate |
-
1960
- 1960-07-29 FR FR834523A patent/FR88M/fr active Active
-
1961
- 1961-07-25 GB GB26856/61A patent/GB922361A/en not_active Expired
- 1961-07-27 US US127154A patent/US3161565A/en not_active Expired - Lifetime
- 1961-07-27 CH CH884561A patent/CH394216A/fr unknown
- 1961-07-27 BE BE606638A patent/BE606638A/fr unknown
- 1961-07-28 ES ES0269442A patent/ES269442A1/es not_active Expired
- 1961-07-28 DK DK312061AA patent/DK105811C/da active
Also Published As
| Publication number | Publication date |
|---|---|
| DK105811C (da) | 1966-11-14 |
| GB922361A (en) | 1963-03-27 |
| CH394216A (fr) | 1965-06-30 |
| BE606638A (fr) | 1961-11-16 |
| FR88M (es) | 1961-01-09 |
| US3161565A (en) | 1964-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES280824A1 (es) | Mejoras introducidas en la preparación de composiciones contra el empañamiento en el cobre | |
| GB754587A (en) | Improvements in the treatment of butyl rubber | |
| ES269442A1 (es) | Procedimiento de preparaciën de orotato de lisina | |
| BE622943A (fr) | Compositions thérapeutiques, contenant des dérivés d'émétine. | |
| ES269440A1 (es) | Procedimiento de preparaciën de nicotina de lisina | |
| FR2290203B1 (es) | ||
| FR1251742A (fr) | Préparation d'acrylates d'aminoalkyle, substitués en position alpha | |
| GB1100443A (en) | 17ª‡-chloroethynyl-13ª‰-ethylgonenolone | |
| ES400623A1 (es) | Procedimiento para la preparacion de una composicion farma-ceutica. | |
| GB936366A (en) | Methylsulphonyl-phenyl compounds | |
| GB1123561A (en) | Improvements in and relating to novel 9ªß,10ª-steroids, methods of producing the same, pharmaceutical preparations containing said 9ªß,10ª-steroids as active substancesand methods of producing said preparations | |
| AU242275B2 (en) | Improvements in or relating to antihypercholecterolemic compositions containing 3,5,3' d-triodothyronine | |
| ES262144A1 (es) | Proceso de preparaciën de una composiciën medicinal | |
| ES405393A1 (es) | Un metodo para la preparacion de una composicion farmaceu- tica adecuada para uso en el tratamiento yno profilaxis de estados alergicos. | |
| GB942981A (en) | Therapeutic composition having a hypotensive action and containing a mixture of 3-hydrazino 6-carbamoyl pyridazine and reserpine | |
| AU5932960A (en) | Improvements in or relating to antihypercholecterolemic compositions containing 3,5,3' d-triodothyronine | |
| AU260667B2 (en) | Improvements in or relating to therapeutic compositions | |
| GB971239A (en) | Therapeutic composition having hypotensive and vasodilator activity | |
| GB903355A (en) | Furfurylmercaptopyridine compounds and preparation thereof | |
| AU252896B2 (en) | Therapeutic composition containing 4-hydroxybutyric acid or salts thereof | |
| GB917575A (en) | Pharmaceutical anti-inflammatory compositions containing glycyrrhetinic acid isomers | |
| GB1047919A (en) | Morpholine derivative, preparation thereof and compositions containing same | |
| GB1330993A (en) | Mixture of l-dopa and 2-imino-5-phenyl-4-oxazolidinone used to treat parkinsons disease | |
| GB904104A (en) | Pharmaceutical compositions containing 5,5-diphenyl-tetrahydroglyoxaline-4-one | |
| ES330057A1 (es) | Mejoras introducidas en la preparacion de composiciones nematocidas. |